Brief: Kura Oncology And Kyowa Kirin Announce Positive Ziftomenib Monotherapy Registrational Trial

Kura Oncology

05/02/2025 21:02

Feb 5 (Reuters) - Kyowa Kirin Co Ltd  4151.T :
    * KURA ONCOLOGY AND KYOWA KIRIN ANNOUNCE POSITIVE ZIFTOMENIB
MONOTHERAPY REGISTRATIONAL TRIAL AND POSITIVE FDA FEEDBACK FOR
UPCOMING FRONTLINE COMBINATION TRIAL DESIGNS
    * KURA ONCOLOGY INC: NDA SUBMISSION FOR ZIFTOMENIB ON TRACK
FOR 2Q
2025
    * KURA ONCOLOGY INC: KOMET-017-IC AND NIC PHASE 3 TRIALS
EXPECTED
TO INITIATE IN 2H 2025

Source text:  ID:nGNX4xK0s3 
Further company coverage:  4151.T 

 ((reuters.briefs@thomsonreuters.com;))